SynthesisWorld journal of urology2025
Impact of ureteroscopy on renal function in solitary kidneys: a systematic review.
Synthesis in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of Mini-Percutaneous Nephrolithotomy and Flexible Ureteroscopy for Treating 1-2 cm Single Stones in Solitary Kidney: Outcomes and Renal Function Impact.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to assess ureteroscopy's impact on renal function in patients with a solitary kidney (SK), where nephron preservation is paramount. With the rising prevalence of SKs due to congenital anomalies or acquired conditions, understanding the safety profile of ureteroscopy, particularly its effects on renal function, seems essential.
methodsA literature search following PRISMA guidelines was conducted to identify reports published until May 2024. Eligible studies were included if they focused on ureteroscopy in SK patients and reported renal function outcomes. Data extraction and bias assessment were performed using standardized protocols as Joanna Briggs Institute's checklist for non-randomized studies. Renal function changes (eGFR or serum creatinine), complications, and follow-up data were analyzed. Outcomes included acute kidney injury (AKI) and persistent renal function deterioration, as defined by the Collège-Français-des-Enseignants-d'Urologie (CFEU) criteria.
results15 studies were included, involving 615 patients. The renal function remained stable in ten (67%) of them, with no significant AKI reported beyond one-month post-procedure. Two studies(13%) reported improved renal function, while three(20%) observed trends toward improvement. The mean stone size ranged from 6 to 37.5 mm, with an operative time of 50-117 min. Complications were reported in 22% of patients, predominantly low-grade(Clavien I-II). Severe complications were rare(0.3% and 2%, respectively). The mean follow-up period was 7.5 months.
conclusionUreteroscopy appears to be a viable and safe option for SK patients, presenting minimal risk of long-term renal deterioration. However, only short-term and heterogenous data are available. Future research with standardized methodologies and long-term evaluations are required to validate these findings.
Indexed as
Identifiers
40549268What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.